| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |